Picture of Vimian AB logo

VIMIAN Vimian AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+3.88%
3m+16.27%
6m+17.56%
1yr+7.86%
Volume Change (%)
10d/3m+9.04%
Price vs... (%)
52w High-3.47%
50d MA+5.52%
200d MA+24.33%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)29.53
PEG Ratio (f)0.86
EPS Growth (f)52.16%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value2.7
Price to Tang. Bookn/a
Price to Free Cashflown/a
Price to Sales4.23
EV to EBITDA24.4

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.07%
Return on Equity1.52%
Operating Margin10.78%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€mn/a71.23173.35281.31331.73367.6414.6467%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a-63.78-86.59+526.06+86.67+31.87n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Vimian AB EPS forecast chart

Profile Summary

Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    January 2nd, 2020
    Public Since
    June 18th, 2021
    No. of Shareholders
    2,259
    No. of Employees
    1,100
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    se flag iconOMX Nordic Exchange Stockholm
    Shares in Issue
    457,118,374
    Blurred out image of a map
    Address
    Riddargatan 19, STOCKHOLM, 114 57
    Web
    https://vimian.com/
    Phone
    Contact
    Maria Tullberg
    Auditors
    Grant Thornton Sweden AB

    VIMIAN Share Price Performance

    Upcoming Events for VIMIAN

    Half Year 2024 Vimian Group AB Earnings Release

    Q3 2024 Vimian Group AB Earnings Release

    Similar to VIMIAN

    Picture of Biogaia AB logo

    Biogaia AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of BoneSupport Holding AB logo

    BoneSupport Holding AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Calliditas Therapeutics AB logo

    Calliditas Therapeutics AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Camurus AB logo

    Camurus AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Cinclus Pharma Holding publ AB logo

    Cinclus Pharma Holding publ AB

    se flag iconOMX Nordic Exchange Stockholm

    FAQ